{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T10:47:05Z","timestamp":1782816425714,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118670","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T14:53:29Z","timestamp":1776610409000},"page":"118670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of Chromene-Phenylpiperazine-Chalcone hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"138","author":[{"given":"Yuanxiu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenze","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bmc.2026.118670_bb0005","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4236\/ym.2018.24025","article-title":"The beneficial effect of enriched environment on pathogenesis of alzheimers disease","volume":"2","author":"Chen","year":"2018","journal-title":"Yangtze Med"},{"issue":"2","key":"10.1016\/j.bmc.2026.118670_bb0010","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"issue":"10284","key":"10.1016\/j.bmc.2026.118670_bb0015","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.bmc.2026.118670_bb0020","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/cmdc.201900261","article-title":"2-phenyloxazole-4-carboxamide as a scaffold for selective inhibition of human monoamine oxidase b","volume":"14","author":"Di Paolo","year":"2019","journal-title":"ChemMedChem"},{"issue":"25","key":"10.1016\/j.bmc.2026.118670_bb0025","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1021\/acsomega.5c00134","article-title":"New prospects in the inhibition of monoamine oxidase-B (MAO-B) utilizing propargylamine derivatives for the treatment of alzheimers disease: a review","volume":"10","author":"Chatzipieris","year":"2025","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bmc.2026.118670_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrn1035","article-title":"Neurobiology of butyrylcholinesterase","volume":"4","author":"Darvesh","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"10.1016\/j.bmc.2026.118670_bb0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/nu12041090","article-title":"Comparative kinetics of acetyl- and butyryl-cholinesterase inhibition by green tea catechins: relevance to the symptomatic treatment of alzheimers disease","volume":"12","author":"Okello","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.bmc.2026.118670_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118071","article-title":"Discovery of a highly selective BChE inhibitor with concomitant anti-neuroinflammatory activity for treating alzheimers disease","volume":"299","author":"Zhao","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118670_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118486","article-title":"Targeting neuroinflammation by activation of the sigma-1 receptor (S1R) and inhibition of butyrylcholinesterase (hBChE) leads to highly potent anti-amnesic compounds in an alzheimers disease mouse model","volume":"305","author":"Reichau","year":"2026","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118670_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118375","article-title":"Exploring the selective butyrylcholinesterase inhibition potential of phenol carbamates: experimental and computational study","volume":"302","author":"Jel\u010di\u0107","year":"2026","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118670_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF00334445","article-title":"Colocalization of cholinesterases with \u03b2 amyloid protein in aged and alzheimers brains","volume":"85","author":"Mor\u00e1n","year":"1993","journal-title":"Acta Neuropathol (Berl)"},{"issue":"22","key":"10.1016\/j.bmc.2026.118670_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216395","article-title":"Can activation of acetylcholinesterase by \u03b2-amyloid peptide decrease the effectiveness of cholinesterase inhibitors?","volume":"24","author":"Zueva","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.bmc.2026.118670_bb0065","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1021\/acs.jmedchem.4c00045","article-title":"Dual inhibitors of brain carbonic anhydrases and monoamine oxidase-B efficiently protect against amyloid-\u03b2-induced neuronal toxicity, oxidative stress, and mitochondrial dysfunction","volume":"67","author":"Giovannuzzi","year":"2024","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2026.118670_bb0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.neuint.2012.08.014","article-title":"Metal dyshomeostasis and oxidative stress in alzheimers disease","volume":"62","author":"Greenough","year":"2013","journal-title":"Neurochem Int"},{"issue":"7","key":"10.1016\/j.bmc.2026.118670_bb0075","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.accounts.9b00248","article-title":"Metal ions in alzheimers disease: a key role or not?","volume":"52","author":"Liu","year":"2019","journal-title":"Acc Chem Res"},{"issue":"5","key":"10.1016\/j.bmc.2026.118670_bb0080","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","article-title":"Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for alzheimers disease","volume":"48","author":"Robert","year":"2015","journal-title":"Acc Chem Res"},{"issue":"5","key":"10.1016\/j.bmc.2026.118670_bb0085","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1039\/D4SC06762B","article-title":"Multi-target-directed therapeutic strategies for alzheimers disease: controlling amyloid-\u03b2 aggregation, metal ion homeostasis, and enzyme inhibition","volume":"16","author":"Yoo","year":"2025","journal-title":"Chem Sci"},{"issue":"11","key":"10.1016\/j.bmc.2026.118670_bb0090","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3390\/ph18111685","article-title":"Multitarget-directed ligands for alzheimers disease: recent novel MTDLs and mechanistic insights","volume":"18","author":"Almaghrabi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.bmc.2026.118670_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11091631","article-title":"Novel phenothiazine\/donepezil-like hybrids endowed with antioxidant activity for a multi-target approach to the therapy of alzheimers disease","volume":"11","author":"Carocci","year":"2022","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.bmc.2026.118670_bb0100","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J Nat Prod"},{"issue":"2","key":"10.1016\/j.bmc.2026.118670_bb0105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ddr.21587","article-title":"Natural products and their derivatives as multifunctional ligands against alzheimers disease","volume":"81","author":"Patil","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.bmc.2026.118670_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104681","article-title":"Chalcone and its analogs: therapeutic and diagnostic applications in alzheimers disease","volume":"108","author":"Thapa","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2026.118670_bb0115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejmech.2019.06.026","article-title":"Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of alzheimers disease","volume":"178","author":"Sang","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"20","key":"10.1016\/j.bmc.2026.118670_bb0120","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1021\/jm200716y","article-title":"Synthesis and study of a series of 3-arylcoumarins as potent and selective monoamine oxidase b inhibitors","volume":"54","author":"Matos","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118670_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2018.00041","article-title":"Structure-activity relationship analysis of 3-phenylcoumarin-based monoamine oxidase b inhibitors","volume":"6","author":"Rauham\u00e4ki","year":"2018","journal-title":"Front Chem"},{"issue":"9","key":"10.1016\/j.bmc.2026.118670_bb0130","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1021\/acs.jmedchem.8b00357","article-title":"Tight-binding inhibition of human monoamine oxidase b by chromone analogs: a kinetic, crystallographic, and biological analysis","volume":"61","author":"Reis","year":"2018","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.bmc.2026.118670_bb0135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.2174\/1567205018666211208140551","article-title":"Multi-target directed ligands (MTDLs): promising coumarin hybrids for alzheimers disease","volume":"18","author":"Bhatia","year":"2021","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"10.1016\/j.bmc.2026.118670_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18030341","article-title":"Coumarin-based prodrugs: therapeutic promise or still confined to preclinical exploration?","volume":"18","author":"Chavez Alvarez","year":"2026","journal-title":"Pharmaceutics"},{"issue":"24","key":"10.1016\/j.bmc.2026.118670_bb0145","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.3390\/molecules27249063","article-title":"Coumarin-induced hepatotoxicity: a narrative review","volume":"27","author":"Pitaro","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118670_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114689","article-title":"Design, synthesis and biological evaluation of novel coumarin derivatives as multifunctional ligands for the treatment of alzheimers disease","volume":"242","author":"Liu","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118670_bb0155","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100599","article-title":"Imino-2 h -chromene based derivatives as potential anti-Alzheimers agents: design, synthesis, biological evaluation and in silico study","volume":"19","author":"Attarroshan","year":"2022","journal-title":"Chem Biodivers"},{"issue":"23","key":"10.1016\/j.bmc.2026.118670_bb0160","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1021\/acschemneuro.2c00520","article-title":"Design, synthesis, and biological evaluation of novel chromanone derivatives as multifunctional agents for the treatment of alzheimer\u2019s disease","volume":"13","author":"Li","year":"2022","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"10.1016\/j.bmc.2026.118670_bb0165","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.3390\/molecules29153514","article-title":"Naturally inspired coumarin derivatives in alzheimers disease drug discovery: latest advances and current challenges","volume":"29","author":"Orioli","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2026.118670_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114358","article-title":"Structure-based design of novel donepezil-like hybrids for a multi-target approach to the therapy of alzheimers disease","volume":"237","author":"Brunetti","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118670_bb0175","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1080\/14756366.2018.1491564","article-title":"Donepezil structure-based hybrids as potential multifunctional anti-Alzheimer\u2019s drug candidates","volume":"33","author":"Piemontese","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2026.118670_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116385","article-title":"Further SAR studies on natural template based neuroprotective molecules for the treatment of alzheimers disease","volume":"46","author":"Singh","year":"2021","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2026.118670_bb0185","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1021\/acs.jmedchem.5b00115","article-title":"Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4 r) agonist activities as potential agents against alzheimers disease: the design of donecopride","volume":"58","author":"Rochais","year":"2015","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118670_bb0190","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bbrc.2018.05.152","article-title":"A rapid and sensitive colorimetric assay for the determination of adenosine kinase activity","volume":"502","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.bmc.2026.118670_bb0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.bmc.2026.118670_bb0200","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2026.118670_bb0205","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/j.bmc.2026.118670_bb0210","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nsb732","article-title":"Structure of human monoamine oxidase b, a drug target for the treatment of neurological disorders","volume":"9","author":"Binda","year":"2002","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.bmc.2026.118670_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114655","article-title":"Monoamine oxidase inhibitors: a concise review with special emphasis on structure activity relationship studies","volume":"242","author":"Bhawna","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118670_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-386467-3.00001-7","article-title":"Structural properties of human monoamine oxidases a and b","volume":"100","author":"Binda","year":"2011","journal-title":"Int Rev Neurobiol"},{"issue":"3","key":"10.1016\/j.bmc.2026.118670_bb0225","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/acs.jmedchem.9b01886","article-title":"Stereoselective activity of 1-propargyl-4-styrylpiperidine-like analogues that can discriminate between monoamine oxidase isoforms a and b","volume":"63","author":"Knez","year":"2020","journal-title":"J Med Chem"},{"issue":"11","key":"10.1016\/j.bmc.2026.118670_bb0230","doi-asserted-by":"crossref","first-page":"9583","DOI":"10.3390\/ijms24119583","article-title":"New insights on the activity and selectivity of MAO-B inhibitors through in silico methods","volume":"24","author":"Pacureanu","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.bmc.2026.118670_bb0235","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1021\/acsomega.2c06939","article-title":"Role of metal cations of copper, iron, and aluminum and multifunctional ligands in alzheimers disease: experimental and computational insights","volume":"8","author":"Puentes-D\u00edaz","year":"2023","journal-title":"ACS Omega"},{"issue":"27","key":"10.1016\/j.bmc.2026.118670_bb0240","doi-asserted-by":"crossref","first-page":"10294","DOI":"10.1021\/acs.inorgchem.2c00502","article-title":"Azo-stilbene and pyridine\u2013amine hybrid multifunctional molecules to target metal-mediated neurotoxicity and amyloid-\u03b2 aggregation in alzheimers disease","volume":"61","author":"Rana","year":"2022","journal-title":"Inorg Chem"},{"issue":"7","key":"10.1016\/j.bmc.2026.118670_bb0245","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid \u03b2 oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.bmc.2026.118670_bb0250","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00044-024-03256-6","article-title":"N-benzyl, n-phenethyl and n-benzyloxybenzamide derivatives inhibit amyloid-beta a\u03b242aggregation and mitigate a\u03b242-induced neurotoxicity","volume":"33","author":"Zhao","year":"2024","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2026.118670_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104895","article-title":"Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer\u2019s disease agents","volume":"111","author":"Ye","year":"2021","journal-title":"Bioorg Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118670_bb0260","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2024.2313682","article-title":"Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating alzheimers disease","volume":"39","author":"Yu","year":"2024","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"10.1016\/j.bmc.2026.118670_bb0265","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.1021\/acsomega.2c06916","article-title":"Antioxidant and antineuroinflammatory mechanisms of kaempferol-3-O-\u03b2-D-glucuronate on lipopolysaccharide-stimulated BV2 microglial cells through the Nrf2\/HO-1 signaling cascade and MAPK\/NF-\u03baB pathway","volume":"8","author":"Lim","year":"2023","journal-title":"ACS Omega"},{"issue":"3","key":"10.1016\/j.bmc.2026.118670_bb0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.bmc.2026.118670_bb0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","article-title":"Recent advances in alzheimers disease: mechanisms, clinical trials and new drug development strategies","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.bmc.2026.118670_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1201982","article-title":"Microglia in alzheimers disease: pathogenesis, mechanisms, and therapeutic potentials","volume":"15","author":"Miao","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.bmc.2026.118670_bb0285","series-title":"Test No. 423: acute oral toxicity - acute toxic class method","author":"OECD","year":"2002"},{"key":"10.1016\/j.bmc.2026.118670_bb0290","series-title":"Pre-Clinical Models","first-page":"105","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","volume":"1916","author":"Kraeuter","year":"2019"},{"issue":"8","key":"10.1016\/j.bmc.2026.118670_bb0295","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neubiorev.2010.04.001","article-title":"The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies","volume":"34","author":"Klinkenberg","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"10.1016\/j.bmc.2026.118670_bb0300","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/acschemneuro.5c00092","article-title":"Development of donor\u2013acceptor architecture-based potential theranostic fluorescent probes for alzheimers disease","volume":"16","author":"Bajad","year":"2025","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.bmc.2026.118670_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111613","article-title":"Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of alzheimers disease","volume":"182","author":"Gutti","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"13","key":"10.1016\/j.bmc.2026.118670_bb0310","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/jcc.10306","article-title":"Detailed analysis of grid-based molecular docking: a case study of CDOCKER\u2014a CHARMm-based MD docking algorithm","volume":"24","author":"Wu","year":"2003","journal-title":"J Comput Chem"},{"issue":"19","key":"10.1016\/j.bmc.2026.118670_bb0315","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2026.118670_bb0320","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"W1","key":"10.1016\/j.bmc.2026.118670_bb0325","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"PLIP 2021: expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.bmc.2026.118670_bb0330","doi-asserted-by":"crossref","first-page":"W443","DOI":"10.1093\/nar\/gkv315","article-title":"PLIP: fully automated protein\u2013ligand interaction profiler","volume":"43","author":"Salentin","year":"2015","journal-title":"Nucleic Acids Res"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:45:11Z","timestamp":1780101911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":66,"alternative-id":["S0968089626001264"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118670","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of Chromene-Phenylpiperazine-Chalcone hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118670"}}